You raise a good point. Placebos used in clinical trials are often designed to mimic the active drug as closely as possible in terms of appearance, taste, and other factors to maintain the "blinding" of both participants and investigators and prevent unblinding. Enteric coating a placebo capsule would be consistent with maintaining the blinding in this trial. Of course, there is no way to be certain what group someone is in during a blinded trial.